FDA and EMA Address Quality and Manufacturing Challenges for Breakthrough Therapies Undergoing Expedited Approval August 5, 2019
FDA introduces new standardized inspection protocols for sterile drug manufacturers to modernize and strengthen oversight November 15, 2018
FTC takes on deceptive stem cell therapy claims for blindness cure and autism treatment November 7, 2018
FDA publishes internal policy on prioritizing surveillance inspections for drug manufacturing sites September 5, 2018
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk May 11, 2018
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk May 11, 2018
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk May 11, 2018
The Crackdown Continues: FDA Takes Action Against Company And Its Autologous Stem Cell Product, Alleging Significant Safety Concerns January 5, 2018
FDA to Rely on Drug Inspections Performed by Certain European Regulatory Authorities Beginning November 1, 2017 October 31, 2017
